Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity

PDF) Spacer acquisition by Type III CRISPR-Cas system during bacteriophage infection of Thermus thermophilus

PDF) A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity

IJMS, Free Full-Text

A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

IJMS, Free Full-Text

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages